TECPR2 mutation-associated respiratory dysregulation: more than central apnea
- PMID: 32209221
- PMCID: PMC7849658
- DOI: 10.5664/jcsm.8434
TECPR2 mutation-associated respiratory dysregulation: more than central apnea
Abstract
Children with rare genetic diseases that cause respiratory dysregulation are at particularly high mortality risk due to development of respiratory failure. The tectonin β-propeller-containing protein 2 (TECPR2) mutations are proposed to cause autophagy defect affecting axonal integrity and development of progressive neurodegenerative and neuromuscular disease. Published TECPR2 mutation cases have described a high prevalence of respiratory failure. We review respiratory pathology in previously published cases and a new case of a 5-year-old girl with previously undescribed TECPR2 mutation demonstrating progressive central apnea due to respiratory cycle dysregulation. This is the first TECPR2 mutation case to demonstrate an ataxic (Biot's) breathing pattern with consistently inconsistent inspiratory and expiratory times and with relatively intact chemoreception during sleep. Therefore, we propose that the central apnea index alone may not be the appropriate marker for mortality risk. Rather, the morbidity and mortality associated with TECPR2 mutations are multisystem in nature and this burden complicates the ultimate needs for ventilation support and prognosis.
Keywords: Biot’s breathing; ataxic breathing; central apnea; circadian rhythm disturbance; respiratory and autonomic dysregulation.
© 2020 American Academy of Sleep Medicine.
Conflict of interest statement
All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. The patient’s parents provided written consent to publication of this de-identified case report. The authors report no conflicts of interest.
Figures


Similar articles
-
TECPR2 Cooperates with LC3C to Regulate COPII-Dependent ER Export.Mol Cell. 2015 Oct 1;60(1):89-104. doi: 10.1016/j.molcel.2015.09.010. Mol Cell. 2015. PMID: 26431026
-
Multimodal bioinformatic analyses of the neurodegenerative disease-associated TECPR2 gene reveal its diverse roles.J Med Genet. 2022 Oct;59(10):1002-1009. doi: 10.1136/jmedgenet-2021-108193. Epub 2021 Dec 21. J Med Genet. 2022. PMID: 34933910
-
Clinical, neuroimaging, and molecular spectrum of TECPR2-associated hereditary sensory and autonomic neuropathy with intellectual disability.Hum Mutat. 2021 Jun;42(6):762-776. doi: 10.1002/humu.24206. Epub 2021 May 11. Hum Mutat. 2021. PMID: 33847017
-
Severe central sleep apnea in a child with biallelic variants in NALCN.J Clin Sleep Med. 2022 Oct 1;18(10):2507-2513. doi: 10.5664/jcsm.10146. J Clin Sleep Med. 2022. PMID: 35808948 Free PMC article. Review.
-
Congenital central hypoventilation syndrome: diagnosis and management.Expert Rev Respir Med. 2018 Apr;12(4):283-292. doi: 10.1080/17476348.2018.1445970. Epub 2018 Feb 28. Expert Rev Respir Med. 2018. PMID: 29486608 Review.
Cited by
-
Progressive cerebellar atrophy caused by heterozygous TECPR2 mutations.Mol Genet Genomic Med. 2022 Feb;10(2):e1857. doi: 10.1002/mgg3.1857. Epub 2022 Jan 7. Mol Genet Genomic Med. 2022. PMID: 34994087 Free PMC article. No abstract available.
-
Novel TECPR2 variant in two cases of hereditary sensory and autonomic neuropathy type 9: insights from genetic characterization and comprehensive literature review.BMC Neurol. 2024 Nov 20;24(1):455. doi: 10.1186/s12883-024-03963-y. BMC Neurol. 2024. PMID: 39567938 Free PMC article. Review.
-
Pathophysiology of Nociception and Rare Genetic Disorders with Increased Pain Threshold or Pain Insensitivity.Pathophysiology. 2022 Aug 2;29(3):435-452. doi: 10.3390/pathophysiology29030035. Pathophysiology. 2022. PMID: 35997391 Free PMC article. Review.
-
Genetic pain loss disorders.Nat Rev Dis Primers. 2022 Jun 16;8(1):41. doi: 10.1038/s41572-022-00365-7. Nat Rev Dis Primers. 2022. PMID: 35710757 Review.
-
Developing antisense oligonucleotides for a TECPR2 mutation-induced, ultra-rare neurological disorder using patient-derived cellular models.Mol Ther Nucleic Acids. 2022 Jun 22;29:189-203. doi: 10.1016/j.omtn.2022.06.015. eCollection 2022 Sep 13. Mol Ther Nucleic Acids. 2022. PMID: 35860385 Free PMC article.
References
-
- Spastic Paraplegia 49, Autosomal Recessive; SPG49, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 615031. https://omim.org/. Updated February 9, 2018. Accessed November 27, 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases